89Zr-Oxine-RY_SW01

· Jiangsu Renocell Biotech Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 89Zr-Oxine-RY_SW01, covering 2024-07-08 to 2024-07-08. Get the full timeline:

Most recent: Clinical Trial Update: 89Zr-Oxine-RY_SW01 Cell Injection for the Treatment of Systemic Sclerosis [Phase 1]